Management of Incidental Breast Lesions Detected at Nuclear Medicine Examinations. Review uri icon

Overview

abstract

  • Nuclear medicine studies are often performed in patients with breast cancer; however, incidental radiotracer uptake in the breasts can be observed in patients with nonbreast malignancies. Benign and malignant lesions can be identified on planar, SPECT, and PET scans. This review will outline the molecular and radiographic imaging appearance of benign and malignant breast lesions on sestamibi scans, bone scans, radioiodine studies, as well as PET studies using fluorine 18 (18F) fluorodeoxyglucose, gallium 68 (68Ga) tetraazacyclododecane tetraacetic acid octreotate (or DOTATATE), 68Ga prostate-specific membrane antigen, and 18F-fluciclovine radiotracers. Recognizing these lesions at molecular and anatomic imaging is important to ensure accurate diagnosis and appropriate management. Keywords: Breast, Mammography, Molecular Imaging, PET/CT, Radionuclide Studies, SPECT/CT © RSNA, 2020.

publication date

  • March 20, 2020

Research

keywords

  • Breast Neoplasms
  • Incidental Findings
  • Nuclear Medicine
  • Positron Emission Tomography Computed Tomography

Identity

PubMed Central ID

  • PMC7983741

Scopus Document Identifier

  • 85121467399

Digital Object Identifier (DOI)

  • 10.1148/rycan.2020190037

PubMed ID

  • 33778704

Additional Document Info

volume

  • 2

issue

  • 2